Morphic

YTD

ALL

Why Robinhood?

You can watch Morphic and buy or sell other stocks, ETFs, and their options commission-free!

About MORF

Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas.

CEO

Praveen P. Tipirneni, MD, MBA

CEOPraveen P. Tipirneni, MD, MBA

Employees

—

Employees—

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2014

Founded2014

Employees

—

Employees—

MORF Key Statistics

Market cap

2.86B

Market cap2.86B

Price-Earnings ratio

-15.81

Price-Earnings ratio-15.81

Dividend yield

—

Dividend yield—

Average volume

538.29K

Average volume538.29K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$57.00

52 Week high$57.00

52 Week low

$19.35

52 Week low$19.35

People also own

Based on the portfolios of people who own MORF. This list is generated using Robinhood data, and it’s not a recommendation.